Femasys Inc. (FEMY)
USD 1.08
(-5.26%)
USD 1.08
(-5.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 9.4 Million USD | 468.84% |
| 2022 | 1.65 Million USD | -26.34% |
| 2021 | 2.24 Million USD | -96.22% |
| 2020 | 59.42 Million USD | 2.42% |
| 2019 | 58.01 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 9.02 Million USD | 3.0% |
| 2024 Q1 | 8.76 Million USD | -6.8% |
| 2023 FY | 9.4 Million USD | 468.84% |
| 2023 Q2 | 1.43 Million USD | -4.87% |
| 2023 Q1 | 1.51 Million USD | -8.57% |
| 2023 Q4 | 9.4 Million USD | 113.23% |
| 2023 Q3 | 4.4 Million USD | 206.72% |
| 2022 Q4 | 1.65 Million USD | -18.38% |
| 2022 Q2 | 2.18 Million USD | 7.02% |
| 2022 Q1 | 2.03 Million USD | -9.11% |
| 2022 FY | 1.65 Million USD | -26.34% |
| 2022 Q3 | 2.02 Million USD | -7.23% |
| 2021 Q1 | 60.24 Million USD | 1.39% |
| 2021 FY | 2.24 Million USD | -96.22% |
| 2021 Q4 | 2.24 Million USD | -10.63% |
| 2021 Q3 | 2.51 Million USD | -19.19% |
| 2021 Q2 | 3.1 Million USD | -94.84% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 59.42 Million USD | 0.0% |
| 2020 FY | 59.42 Million USD | 2.42% |
| 2019 FY | 58.01 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 92.572% |
| AngioDynamics, Inc. | 112.08 Million USD | 91.611% |
| AtriCure, Inc. | 147.76 Million USD | 93.636% |
| Avinger, Inc. | 19.97 Million USD | 52.918% |
| Azenta, Inc. | 351.22 Million USD | 97.323% |
| BioLife Solutions, Inc. | 75.05 Million USD | 87.471% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.771% |
| Daxor Corporation | 858.75 Thousand USD | -994.981% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 42.354% |
| GlucoTrack, Inc. | 1.7 Million USD | -450.541% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 85.374% |
| Hologic, Inc. | 4.02 Billion USD | 99.766% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.583% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.54% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -15.986% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 80.762% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -1324.871% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -1324.871% |
| Masimo Corporation | 1.67 Billion USD | 99.439% |
| Microbot Medical Inc. | 3.82 Million USD | -145.772% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 62.503% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.163% |
| Nephros, Inc. | 3.5 Million USD | -168.434% |
| NovoCure Limited | 783.63 Million USD | 98.8% |
| NEXGEL, Inc. | 4.78 Million USD | -96.351% |
| NEXGEL, Inc. | 4.78 Million USD | -96.351% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 89.124% |
| OraSure Technologies, Inc. | 52.17 Million USD | 81.977% |
| Pro-Dex, Inc. | 23.34 Million USD | 59.717% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 42.817% |
| Predictive Oncology Inc. | 6.14 Million USD | -53.011% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -37.378% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.736% |
| Repligen Corporation | 853.2 Million USD | 98.898% |
| Sanara MedTech Inc. | 29.28 Million USD | 67.889% |
| STAAR Surgical Company | 102.73 Million USD | 90.847% |
| Sharps Technology, Inc. | 3.85 Million USD | -143.924% |
| Utah Medical Products, Inc. | 7.14 Million USD | -31.606% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.769% |
| Jin Medical International Ltd. | 8.92 Million USD | -5.366% |